A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome
NCT02915159
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Sjogrens Disease
Interventions
BIOLOGICAL:
Abatacept
OTHER:
Placebo
Sponsor
Bristol-Myers Squibb